Acambis Inc.
14Patents
0Active
14Granted
33Portfolio score
Filing activity: Jul 23, 1998 → Feb 26, 2004
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6969520B2 | Active immunization against clostridium difficile disease | Physics | 57 | Expired |
| US6680168B2 | Passive immunization against clostridium difficile disease | Human Necessities | 52 | Expired |
| US7361352B2 | Influenza immunogen and vaccine | Emerging Cross-Sectional Technologies | 44 | Expired |
| US6696281B1 | Chimeric flavivirus vaccines | Emerging Cross-Sectional Technologies | 35 | Expired |
| US6585975B1 | Use of Salmonella vectors for vaccination against helicobacter infection | Emerging Cross-Sectional Technologies | 19 | Expired |
| US6962708B1 | Chimeric flavivirus vaccines | Emerging Cross-Sectional Technologies | 18 | Expired |
| US6682883B1 | Diagnosis of flavivirus infection | Emerging Cross-Sectional Technologies | 15 | Expired |
| US6878372B2 | Methods of preventing and treating flavivirus infection in animals | Emerging Cross-Sectional Technologies | 11 | Expired |
| US7459160B2 | Chimeric flaviviruses | Emerging Cross-Sectional Technologies | 9 | Expired |
| US7507415B2 | West nile virus vaccine | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6723325B1 | Smallpox vaccine | Chemistry; Metallurgy | 6 | Expired |
| US7115270B2 | Smallpox vaccine | Chemistry; Metallurgy | 6 | Expired |
| US6576244B1 | LT and CT in parenteral immunization methods against helicobacter infection | Human Necessities | 5 | Expired |
| US7569383B2 | Chimeric flavivirus vectors | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.